Introduction
G-protein coupled receptors (GPCRs) can modulate a wide range of physiological processes being involved in numerous diseases. All GPCRs share a common structure, including an extracellular N-terminus, seven-α-helix transmembrane regions connected by three alternating extracellular loops (ECL1-3), three intracellular loops (ICL1-3) and an intracellular C-terminus. A disulfide bond connecting the ECL-2 and the top of transmembrane (TM) helix 3 is found in > 90% of all GPCRs and has been suggested to be important for receptor conformation, ligand recognition and functioning (Angers et al., 2002; Kclo et al., 2005; Park et al., 2004; Rios et al., 2001; Venkatakrishnan et al., 2013; Wheatley et al., 2012 Wheatley et al., , 2007 . Other disulfide bonds in the extracellular side have been described for different receptors (Storjohann et al., 2008) .
The serotonin 2 A receptor (5-HT 2A ) is a class A GPCR associated with schizophrenia as an important target for atypical antipsychotic drugs (González-Maeso et al., 2008; Roth et al., 1998) . This receptor was one of the first types of GPCR for which the functional selectivity phenomenon was observed, with different ligands differentially activating phospholipase A 2 (PLA 2 ) -inducing arachidonic acid (AA) release -and phospholipase C (PLC) -resulting in the production of inositol phosphate (IP) formation and diacylglycerol (DAG) -for the same receptor (Berg et al., 1998; Felder et al., 1990; Hoyer et al., 1994; Urban et al., 2007) .
We have previously demonstrated the existence of 5-HT 2A homooligomers in the human brain and in recombinant cell lines, moreover a negative cooperativity phenomenon for certain ligands was observed, such as clozapine, through the PLA 2 signalling pathway (Albizu et al., 2006; Brea et al., 2009; Iglesias et al., 2016) .
Recent reports indicate that lysergic acid diethylamide (LSD) displays slow binding kinetics at serotonin 5-HT 2A and 5-HT 2B receptors. In view of the 5-HT 2B crystal structure, it has been proposed that this may be due to a lid formed by ECL-2 at the entrance to the binding pocket (Wacker et al., 2017) .
From a structural viewpoint, the serotonin 5-HT 2A receptor contains a total of fifteen cysteines, seven on the extracellular side and one at the top of TM3. The GPCR conserved disulfide bridge is formed by Cys 148 (TM3) and Cys 227 (ECL-2) ( Fig. 1) . We hypothesized that this disulfide bridge may determine serotonin 5-HT 2A receptor functions such as receptor activation, functional selectivity and ligand recognition. There were several studies disrupting the conserved disulfide bond in different GPCRs by mutagenesis studies, but it has been described that mutant receptors were restricted to endoplasmic reticulum showing lower membrane expression (Barington et al., 2016; Conner et al., 2007; Rummel et al., 2013; Scholl and Wells, 2000) , thus the effect of disulfide bridges on ligand binding or function can be masked by the effect due to the mutation itself.
The aim of this study was to characterize the effect of the reduction in the number of disulfide bridges in serotonin 5-HT 2A receptor by employing the solvent accessible reducing agent dithiothreitol (DTT). This allows disrupting the disulfide bridges while keeping the primary structure of serotonin 5-HT 2A receptors. 
Material and methods

Drugs and reagents
Cell culture
Cells were grown at 37°C in a 5% CO 2 humidified atmosphere. Chinese hamster ovary (CHO) cells stably expressing human serotonin 5-HT 2A receptors at a density of ̴ 200 fmol/mg protein (CHO-FA4 cells, passages between 12 and 25) were maintained in standard tissue culture plates (150 mm in diameter) in Dulbecco's Modified Eagle's Medium-F12 (DMEM-F12; Gibco) supplemented with 10% (v/v) foetal bovine serum (FBS; Sigma Aldrich), 1% L-glutamine (Sigma Aldrich), 100 U/ml penicillin/0.1 mg/ml streptomycin (Sigma Aldrich) and 300 μg/ml hygromycin (Invitrogen).
Human Embryonic Kidney 293T cells (HEK 293T) (passages between 10 and 18) were maintained in standard tissue culture plates (150 mm in diameter) in Dulbecco's Modified Eagle's Medium (DMEM; Sigma Aldrich) supplemented with 10% (v/v) FBS, 1% (v/v) Glutamax (Gibco) and 100 U/ml penicillin/0.1 mg/ml streptomycin.
Membrane preparations of human serotonin 5-HT 2A receptors
Prior to being harvested, stably transfected cells were grown for 24 h in DMEM-F12 supplemented with 10% (v/v) dialyzed FBS without hygromycin. The culture medium was aspirated and the cells were washed twice with ice-cold phosphate buffered saline (PBS) before being scraped from the culture plate in PBS and pelleted by centrifugation at 800 × g, 15 min at 4°C. The cell pellet was resuspended in PBS or PBS supplemented with 20 mM DTT and incubated for 10 min at 37°C. The cell suspension was then centrifuged under the same conditions. The cell pellet was washed in ice-cold PBS, resuspended in 50 mM Tris-HCl, pH = 7.5 at 4°C, and homogenized with a Polytron homogenizer. The homogenate was centrifuged at 48,000 × g for 40 min at 4°C and the resulting pellet was resuspended in 50 mM TrisHCl, pH = 7.5, at 4°C. The protein concentration was determined by the Bradford method with the Bio-Rad Protein Assay (Bio-Rad, Fig. 1 . A secondary structure model of the human serotonin 5-HT 2A receptor. The location of 15 cysteine residues (black circles) and the conserved disulfide bridge are indicated (modified from www.gpcrdb.org).
California) and bovine serum albumin as standard.
Saturation binding assays with human serotonin 5-HT 2A receptors
Membranes obtained from CHO-FA4 expressing serotonin 5-HT 2A receptors prepared either in the absence or presence of 20 mM DTT were incubated with eight different concentrations of [ 3 H]LSD (83.6 Ci/mmol) in the range 0.16-20 nM (80 μg of protein per well) in the incubation buffer (50 mM Tris-HCl, pH = 7.5). Non-specific binding was determined by the addition of 1 μM methysergide. The reaction mixture was incubated at 37°C for 30 min. The reaction samples were transferred to a multiscreen GF/B 96-well plate (Millipore) pretreated with 0.5% polyethylenimine (PEI, Sigma Aldrich) and were then filtered and washed six times with 250 μl wash buffer (50 mM Tris-HCl, pH 6.6). The filters were dried and 30 μl Universol (MP Biomedicals, Santa Ana, California) was added to each well. The radioactivity was detected in a microplate beta scintillation counter (Microbeta Trilux, PerkinElmer).
Binding kinetics: determination of association and dissociation rates
Membranes obtained from CHO-FA4 expressing serotonin 5-HT 2A receptors prepared either in the absence or presence of 20 mM DTT were incubated in 50 mM Tris-HCl (pH 7.5) and 1 nM [ 3 H]LSD (83.6 Ci/mmol) in a 96 well plate (80 μg of protein per well) at 37°C. Association was measured at different times between 0 and 60 min, and dissociation was initiated 30 min later by addition of 1 µM methysergide at different times between 0 and 180 min. Non-specific binding was measured in the presence of 1 µM methysergide. Samples were transferred to a multiscreen GF/B 96-well plate pretreated with 0.5% PEI and the subsequent procedure was the same as described in saturation binding assays section.
Competition binding to human serotonin 5-HT 2A receptors
Serotonin 5-HT 2A receptor competition binding experiments were carried out with membranes from CHO-5-HT 2A cells that were either pretreated or not pretreated with 20 mM DTT (in the preparation protocol). On the day of the assay, membranes were defrosted and resuspended in incubation buffer (50 mM Tris-HCl, pH 7.5). Each reaction well of a 96-well plate contained 80 μg of protein, 1 nM [ 3 H]LSD (83.6 Ci/mmol) and different concentrations of clozapine. Non-specific binding was determined in the presence of 1 μM methysergide. The reaction mixture was incubated at 37°C for 30 min. Samples were transferred to a multiscreen GF/B 96-well plate pretreated with 0.5% PEI and the subsequent procedure was the same as described in saturation binding assays section. Measurement of AA release and IP accumulation was performed simultaneously in the same well, as previously described (Iglesias et al., 2016) .
Cells were seeded into 96-well tissue culture plates at a density of 2 × 10 4 cells/well. After 24 h, the medium was replaced with serum-free medium containing 10 μCi/ml [ 
Bioluminiscence resonance energy transfer (BRET) assays for assessment of receptor dimerization
BRET methodology is based on the fact that the degree of physical proximity (< 100 Å) between molecules can be assessed in living cells by the level of energy transfer between the energy donor Renilla luciferase (RLuc) and a fluorescence acceptor, the yellow fluorescence protein (YFP). BRET saturation experiments were performed using HEK293T cells previously seeded into 100-mm dishes at a density of 2 × 10 6 cells and transfected 24 h later with a fixed amount of RLuc-N2-5-HT 2A luciferase donor plasmid (0.06 μg DNA/dish) and with increasing amounts of pcDNA3-5-HT 2A -YFP acceptor plasmid (from 0.06 to 4 μg DNA/dish) by using linear polyethylenimine MW-25000 at a DNA/polyethylenimine ratio of 1:6 (Jenkins et al., 2010) . In each transfection mix, the total amount of DNA was maintained constant by the addition of empty vector up to 5 μg. The transfection medium was aspirated 24 h after transfection. The cells were then washed with PBS and 5 × 10 4 cells/well were seeded in a 96-well plate pretreated with 0.1 mg/ml poly-D-lysine hydrobromide (Sigma Aldrich). Forty-eight hours post transfection, the cells were washed with HBSS and incubated with HBSS or HBSS supplemented with 20 mM DTT for 10 min at 37°C. The YFP expression was then quantified in each well by direct measurement of fluorescence emission at 530 nm (excitation wavelength of 480 nm). The buffer was removed and coelenterazine h (Molecular Probes) was added to a final concentration of 5 μM in HBSS. The plate was incubated for 10 min at 37°C in darkness and BRET was subsequently quantified by dual bioluminescence measurement (370-480 nm for RLuc emission and 520-570 nm for YFP emission). Ten minutes later, total luminescence (400-700 nm) was quantified as a measure of donor expression. All measurements were performed in an Infinite ® M1000Pro (TECAN) microplate reader. The BRET ratio was calculated as emission at 520-570 nm/emission at 370-480 nm. Net BRET was defined as the 530 nm/485 nm ratio of cells co-expressing donor (RLuc) and acceptor (YFP) plasmid constructs minus the BRET ratio of cells expressing only the donor (RLuc) plasmid construct in the same experiment. Results were expressed as milli net BRET units (mBU), which correspond to the net BRET ratio values multiplied by 1000. BRET saturation curves were obtained by representing mBU as a function of the acceptor expression/donor expression, as determined by direct quantification of fluorescence and total luminescence emission. Data were fitted to the hyperbolic function (one binding site) with GraphPad Prism 4.0 software. The equation parameters maximum number of binding sites (B max ) and equilibrium dissociation constant (K d ) corresponded respectively to the maximal BRET signal obtained (BRET max ) and BRET 50 , i.e. the acceptor/donor ratio providing 50% of the BRET max .
2.9. In silico structural model of ECL-2 on human serotonin 5-HT 2A receptor before and after disruption of the Cys
-bond
In order to build a serotonin 5-HT 2A receptor model, we used the recently determined structure of the related serotonin 5-HT 2B receptor in complex with LSD (PDB ID 5TVN) as template. We first aligned the Uniprot sequence of the serotonin 5-HT 2A receptor to the one of the serotonin 5-HT 2B receptors with MOE software (Molecular Operating Environment (MOE) software, http://www.chemcomp.com/ software.htm). We then built a homology model and optimized the model with the AMBER12: EHT force field included in the MOE software (Case et al., 2012) . Finally, the model was stereochemically validated with PROCHECK (Laskowski et al., 1993) .
In order to evaluate the conformational space of the ECL-2 with an intact and broken cysteine bond, we explored both conditions by performing a Low Mode Search analysis of this region with MOE software (with the AMBER12: EHT force field, Born solvation and a temperature of 300 K). The following conditions were applied for the Low Mode Search: rejection limit of 100, iteration limit of 500, RMSD gradient of 0.1 and maximum number of energy minimization iterations of 500. The tolerance for equal conformations was set to a RMSD of 1, while the energy window was set to 100. Using these settings, we obtained 495 conformations for the receptor with a broken disulfide bridge and 490 different conformations for the receptor with an intact disulfide bridge. From this pool of conformations, we selected the best 200 conformations in terms of energy and depicted them by a stride of 2 in Fig. 8 .
Data analysis
Nonlinear fitting of the concentration-response curves was conducted with Prism 4.0 software (GraphPad Software, La Jolla, USA) by applying both a four-parameter logistic equation and a two-site competition equation. Dissociation and association kinetic data were fitted to a one-phase exponential decay equation and a one-phase exponential association equation, respectively. Statistical comparisons between fits were performed by extra sum-of-squares F test (Giraldo et al., 2002) . Statistical significance was set at P < 0.05. Statistical comparisons between binding and functional parameters (treated relative to control) were performed by Student's t-test with SPSS statistics 20 (IBM). Statistical significance was set at P < 0.05. The association rate constant (k on ) was calculated by using the following equation:
where k obs is the observed association rate constant and k off the dissociation rate constant (k off ). Fig. 2 . DTT treatment induced a statistically significant decrease in B max (P < 0.05, Student's unpaired t-test) without affecting the K d value ( Fig. 2; Table 1 ). Kinetic analysis of [ 3 H]LSD binding revealed statistically significant differences in the percentage of specific binding in association experiments in which a decrease of 40.54% in cells treated with DTT was observed (P < 0.05, Student's unpaired t-test). k on and association half time (t 1/2 ) remained unaltered relative to the control ( Fig. 3A ; Table 2 ).
In the dissociation experiments, no change in k off was observed. The residence times of LSD (calculated as 1/ k off ) were 78.3 min for control and 57.2 min for DTT-treated cells. The K d value calculated from k off / k on ratio for DTT treatment was similar to that observed in saturation experiments, while the dissociation constant calculated for control was slightly lower than the observed in saturation experiments, but no significant differences were observed ( Fig. 3B ; Table 2 ). In order to test the effects of DTT on antagonist binding, we carried When IP accumulation was measured, the 5-HT decrease by 25.36% in the maximal response (E max ) for cells treated with DTT (%E max of 98.82 ± 2.75 for control cells and %E max of 73.46 ± 2.39 for 20 mM DTT-treated cells) (P < 0.001, Student's unpaired t-test). No significant differences in 5-HT potency were observed (pEC 50 of 6.25 ± 0.07 for control and pEC 50 of 6.08 ± 0.09 for 20 mM DTT treated) (Fig. 5) .
Clozapine concentration-response curves were then constructed for the absence and presence of different concentrations of DTT (5, 20 and 40 mM). We previously observed that clozapine differentially modulates phospholipase A 2 and phospholipase C pathways coupled to serotonin 5-HT 2A receptors: it inhibits 5-HT-induced stimulation of the PLA 2 pathway with a biphasic profile, while it inhibits the PLC pathway with a monophasic profile (Brea et al., 2009; Iglesias et al., 2016) . DTT treatment induced a statistically significant decrease of 1 μM 5-HT-induced activation in the two signalling pathways studied (P < 0.001, Student's unpaired t-test) ( Fig. 6 ; Tables 4, 5), but no significant differences in the pIC 50 values for either signalling pathway were observed relative to the control. 
Treatment with DTT did not disrupt 5-HT 2A homodimers
To test the possible involvement of disulfide bonds in 5-HT 2A dimerization, we used BRET saturation assays to examine the effect of the reducing agent DTT on 5-HT 2A dimerization. HEK293T cells were cotransfected with a constant amount of RLuc-N2-5-HT 2A donor plasmid and increasing amounts of pcDNA3-5-HT 2A -YFP acceptor plasmid and they were treated or not treated (control) with DTT prior to determination of BRET efficacy. The results showed an increase in BRET signals as a function of increasing acceptor/donor expression in control cells that could be fitted to a rectangular hyperbolic function (Fig. 7) . Neither the amplitude nor the shape of the BRET saturation curves were affected by DTT treatment (Fig. 7) . The experiments performed yielded BRET max and BRET 50 values for the DTT-treated cells (mean ± S.E.M., n = 4) of 96.30 ± 4.086% and 110.0 ± 9.134% of the values obtained for untreated cells, resulting in no statistically significant differences between both conditions (P = 0.4683 for BRET max and P = 0.2689 for BRET 50 , Paired t-test). This suggests that the possible effects of DTT on the integrity of cysteine-bonds do not alter the homodimerization state of the serotonin 5-HT 2A receptors in the transfected cells.
In silico structural model of ECL-2 binding to the human serotonin 5-HT 2A receptor before and after DTT treatment
In order to analyze how DTT treatment may affect the structural integrity of the serotonin 5-HT 2A receptor binding site, we performed a structural analysis of the changes in conformational freedom of ECL-2 before and after DTT treatment. To do so, we started from a model of the serotonin 5-HT 2A receptor (see Methods). Using this structure, the ECL-2 region of two different receptor systems was subjected to a Low Mode Analysis with MOE software. In the first, the cysteine bond between ECL-2 and helix 3 was preserved (as found in untreated The values represent the mean of three independent experiments each performed in triplicate. a indicates P < 0.05 treated versus control cells (Student's unpaired t-test). The values represent the mean ± S.E.M of at least four independent experiments each performed in duplicate. a indicates P < 0.001 treated versus control cells (Student's unpaired t-test).
A. Iglesias et al. European Journal of Pharmacology 815 (2017) 138-146 receptors). In the second, the bond was broken, thus mimicking the effects of DTT. As we can see in the top view of both receptor conditions in Fig. 8 , these result in different populations of ECL-2 conformations.
In Fig. 8A , we see how in the untreated receptor (with an integer cysteine bond, in yellow vdW representation) ECL-2 is more constrained to the extracellular region. This ECL-2 constraint seems to be important for maintaining an open binding pocket that can accommodate an orthosteric ligand (e.g. LSD, orange VdW, see Fig. 8C ). Conversely, in the receptor with a broken cysteine bond (yellow vdW representation, Fig. 8B ) ECL-2 adopts a wider variety of conformations. Some of these conformations protrude deeper into the receptor orthosteric binding pocket leading to collapse of the pocket. A shrunken binding pocket would be incapable of accommodating LSD (orange VdW, Fig. 8D ) due to a large degree of overlap of ECL-2 with the orthosteric ligand. These observations are consistent with the lower availability of LSD binding sites observed in our experiments.
Discussion
The major finding of this study was that rupture of the disulfide bridge in the serotonin 5-HT 2A receptor with the reducing agent DTT alters its binding and activation properties by disturbing its conformation without changing its homodimeric structure.
Ligand binding and the function of the serotonin 5-HT 2A receptor after treatment with the reducing agent DTT was analyzed. We used The values represent mean ± S.E.M of at least thirteen independent experiments each performed in triplicate. a indicates P < 0.001 for treated versus control cells (Student's unpaired t-test).
A. Iglesias et al. European Journal of Pharmacology 815 (2017) 138-146 that treatment with DTT causes a decrease in the ligand binding on β-adrenergic receptors (Dohlman et al., 1990; Noda et al., 1994; Vauquelin et al., 1979) , dopamine D 2 receptors (Reader et al., 1992) , serotonin 5-HT 1A receptors (Harikumar et al., 2000) and prostacyclin receptors (Stitham et al., 2006) , among others. However, an increase in ligand binding or activation has also been observed in other receptors. Some examples are the histamine H 1 receptor (Carman-Krzan et al., 1984; Dickenson and Hill, 1994; Donaldson and Hill, 1986a , 1986b , 1986c , β-adrenergic receptors (Pedersen and Ross, 1985) and N-methyl-D-aspartate (NMDA) receptors (Reynolds et al., 1990; Talukder et al., 2011) . According to the in silico study, the reduced number of binding sites may be the result of the collapse of the binding pocket caused by destruction of the disulfide bridge. Similar effects on receptor pharmacology have been observed for the β 1 -adrenergic receptor (Vauquelin et al., 1979) . However, other studies showed that DTT treatment induced a decrease in B max and changes in K d values (Dorn, 1990; Huang and Rorstad, 1989; Noda et al., 1994; Reader et al., 1992; Wright and Drummond, 1983) . Both studies explained the results obtained based on the reduction of a disulfide bridge in the receptor that is important for ligand binding, either by direct participation in ligand recognition or its proximity to binding site.
In a further step, we studied DTT-induced modulation of receptor signalling. We first evaluated the effect of DTT treatment in 5-HTmediated PLC pathway activation by determining concentration-response curves in the absence and presence of 20 mM DTT. The results showed a statistically significant decrease in E max of IP accumulation in the presence of DTT, although the potency values were unchanged.
Given that clozapine shows functional selectivity with a combination of biphasic and monophasic inhibition curves in both binding and functional assays (Brea et al., 2009 ), we constructed concentration-response curves for clozapine in the absence and presence of different concentrations of DTT. The results showed a statistically significant decrease in 5-HT E max in both pathways, although the clozapine inhibition profiles observed in treated cells were the same relative to the control. The curves were the same in both untreated and DTT-treated receptors (monophasic in the PLC pathway and biphasic in the PLA 2 pathway) and potency values were unchanged.
Similar results were found in rat forebrain synaptoneurosomes, in which DTT also produced dose-dependent inhibition of IP accumulation produced by glutamate and potassium in the metabotropic glutamate receptor (Vignes et al., 1992) . In the prostacyclin receptor, a decrease in cAMP production was also observed when β-mercaptoethanol (β-ME) was used as the reducing agent, with no effect on the EC 50 value. In the same study, competition experiments carried out in the presence of β-ME or DTT showed a decrease in [ 3 H]iloprost specific binding without any change in affinity (Stitham et al., 2006) . According to the results of our functional experiments, the dimeric structure of serotonin 5-HT 2A receptors was conserved after DTT treatment. However, western-blot experiments have shown that DTT treatment also causes the rupture of GPCR dimers on different receptors (Berthouze et al., 2007; Fay and Farrens, 2013; Michineau et al., 2006; Romano et al., 1996; Zeng et al., 1999; Zeng and Wess, 2000) . In order to clarify this question, BRET experiments were carried out to confirm the preservation of the dimeric structure of these receptors. As expected, DTT treatment did not modify the BRET signal, suggesting that breakage of disulfide bridges did not disrupt the dimer. Nevertheless, the binding and functional results suggest that, after DTT treatment, the TM3-ECL-2 disulfide bridge is disrupted, thus allowing the receptor to adopt different conformations. This is consistent with results reported by Lin et al. (1996) , who showed that the secondary structure of the β 2 -adrenergic receptor had not been disturbed after DTT treatment, but it induced a reversible conformational change in the tertiary structure of the receptor.
We have discarded that DTT may be disrupting cysteine bridges in the intracellular side that could condition the second messenger coupling because DTT is a reducing agent exerting its action in solvent accessible domains, disrupting therefore only extracellular disulfide bridges. Extracellular loops are known to play important functional roles in ligand binding and receptor activation (Avlani et al., 2007; Barington et al., 2016; Conner et al., 2007; Kclo et al., 2005; Nguyen et al., 2016a, b; Palczewski et al., 2000; Peeters et al., 2011; Ragnarsson et al., 2015; Scarselli et al., 2007; Wheatley et al., 2012 Wheatley et al., , 2007 . Recently reported crystal structures show that the conserved disulfide bridge forces ECL-2 to form a lid over the binding pocket, and that ECL-2 contains well defined but rather different secondary structures within the different receptor families (Palczewski et al., 2000; Rasmussen et al., 2007; Shi and Javitch, 2004; Shimamura et al., 2011; Warne et al., 2008) . It has also been speculated that the ECL-2 adopts different conformations during ligand binding and receptor activation, first allowing the ligand to enter the binding pocket (open conformation) and secondly stabilizing ligand-stabilized receptor conformations (closed over the ligand). The ECL-2 thus functions as a gatekeeper for entry into the orthosteric binding site. Moreover, ECL-2 is also known to be associated with ligand selectivity by adopting distinct conformations on empty receptor or bound ligand and interacting differently between agonists (total or partial), inverse agonists or antagonists (Banères et al., 2005; de Zwart et al., 1999; Unal et al., 2010) . The correct orientation of the ECL-2 is thus restrained by the conserved disulfide bond and plays an important role in producing different functional states of the receptor.
Furthermore, in serotonin 5-HT 2A and 5-HT 2B receptors a decrease in E max was observed in the β-arrestin pathway when L229A and L209A were mutated respectively, but not in PLC pathway (Wacker et al., 2017) . Our results complement the findings of the aforementioned study by showing that the disulfide bridge is disrupted without modifying the primary structure of serotonin 5-HT 2A receptor. A decrease in E max was thus also obtained in PLA 2 and PLC pathways, suggesting a role for the disulfide bridge in ligand binding and activation.
In summary, our results show that the disulfide bridge between TM3 and ECL-2 is essential for serotonin 5-HT 2A receptor signalling in both PLA 2 and PLC pathways, but not for the homodimeric nature of these receptors. This reveals the integrity of the ECL-2 epitope, which should be explored for developing novel ligands acting as allosteric modulators of serotonin 5-HT 2A receptors.
